Atorvastatin API Market – 2019 Trends, Growth Insight, Size, Share, Competitive Analysis, Statistics, Regional, And Global Forecast To 2023

Aug 6, 2019

Global Atorvastatin API Market: Information by Application (Hypercholesterolemia, Hypertriglyceridemia, Dyslipidemia) and Region (North America, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023

Pune, India - August 6, 2019 /MarketersMedia/ —

Atorvastatin API Market – Overview

The increasing obesity rates, coupled with an increased incidence of cholesterol problems, is increasing the demand for atorvastatin. Reports that review the healthcare industry have been presented by Market Research Future, which produces reports on industry verticals that appraise the market expansion and prospects. The market is positioned to achieve a CAGR of 3.34% while earning revenues worth USD 4,25,804.16 thousand by 2023.

The need to regulate vital cardiovascular functions is the primary factor fuelling the atorvastatin API market globally. The surging use of atorvastatin to treat cardiovascular diseases is fuelling the development of the market for atorvastatin APIs. The market is expected to be motivated market expansions that are expected to be carried out by industry leaders in the approaching CAGR in the forecast period.

Get Free Sample of This Report @ https://www.marketresearchfuture.com/sample_request/7885

Atorvastatin API Market Segmental Analysis

The segmental study of the atorvastatin API market is carried out on the basis of application and region. The application basis of segmenting the atorvastatin API market is carried out on the basis of hypertriglyceridemia, hypercholesterolemia, dyslipidemia, and others. The hypercholesterolemia segment is anticipated to control the market to touch USD 2,10,753.23 thousand by the end of 2023. The high incidence of hypercholesterolemia is anticipated to initiate positive market growth. Also, the segment is expected to display the uppermost CAGR of 4.09% from 2018 to 2023. The regions counted in the atorvastatin API market are Europe, North America, Asia Pacific, the Middle East, and Africa.

Atorvastatin API Market Detailed Regional Analysis

The regional review of the atorvastatin API market includes region such as Europe, North America, Asia Pacific, the Middle East, and Africa. The North American region was in charge of the largest market portion of 40.64% in 2017, and the regional market is expected to record a CAGR of 3.10 % through the forecast period. Moreover, the Asia Pacific is projected to utilize the fastest CAGR. The Chinese regional market is projected to display the maximum development rate of 5.86 % during the forecast period from 2018 to 2023. The European regional market is appraised to surpass USD 1,31,094.04 thousand by the year 2023. The high prevalence of mixed dyslipidemia and hypercholesterolemia are impelling the growth of the Atorvastatin API market in the region. France is the key supplier to the development of the regional market, followed by the UK.

Atorvastatin API Market Competitive Analysis

The trade-offs between the resources needed to manage the challenges in the market are being carried out increasingly to improve the market’s scope for development. The need to establish cost-benefit analysis is leading to enhanced product development in the market. The state of the assets is also thoroughly examined to determine whether an investment is required to maintain the marketing system in its existing, unimproved state. The market competitors are also carefully scrutinizing whether intervention is required to ensure efficient use of society’s resources. The development of the alternative courses of action in terms of both their expenses and consequences are steering the growth of the market. The market players are concentrating on strategies that lead to the highest degree of development in the market. They are also making the most effective use of resources which is dependent on an effective appraisal and planning process.

The outstanding leaders in the Atorvastatin API Market globally are Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Morepen Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Anuh Pharma Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India).

Atorvastatin API Industry Updates:

Nov 2018 Zydus Cadila, a well-known Drug maker, has announced that it has received approval from the US health regulator to promote Atorvastatin Calcium tablets, a cholesterol-lowering drug. The group based out of Ahmedabad has obtained final endorsement from the US Food and Drug Administration (USFDA) to sell the drug in the concentrations of 10 mg, 20 mg, 40 mg, and 80 mg respectively.

Get access to full summary @ https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885

Source URL: https://marketersmedia.com/atorvastatin-api-market-2019-trends-growth-insight-size-share-competitive-analysis-statistics-regional-and-global-forecast-to-2023/88904758

Source: MarketersMedia

Release ID: 88904758

More News

Town on the move with derby win
Sep 19, 2026
Town on the move with derby win

Unbeaten Faversham Town moved up to third place with a derby win over Herne Bay.

FA Cup round-up: Nine Kent clubs make Monday’s draw
Sep 19, 2026
FA Cup round-up: Nine Kent clubs make Monday’s draw

Nine Kent clubs will be in Monday’s FA Cup third qualifying round draw.

Football fixtures and results
Sep 19, 2026
Football fixtures and results

Catch up with all the week’s football fixtures and results here.

Report: Gillingham make it three in a row!
Sep 19, 2026
Report: Gillingham make it three in a row!

Gillingham’s impressive form continued on Saturday with a win over Bristol Rovers at Priestfield.

Matchday Live: Gillingham v Bristol Rovers, Dover v Folkestone, Tonbridge v Ramsgate
Sep 19, 2026
Matchday Live: Gillingham v Bristol Rovers, Dover v Folkestone, Tonbridge v Ramsgate

Follow today’s football action, including Gillingham at home to Bristol Rovers, in our live blog.

Gareth Ainsworth: ‘I’ve got through this period – now I’m ready to deliver’
Sep 18, 2026
Gareth Ainsworth: ‘I’ve got through this period – now I’m ready to deliver’

Gareth Ainsworth believes Gillingham have turned a corner after finally getting the chance to build the team he wanted.

Promotion-chasing Kent wrap up vital win
Sep 17, 2026
Promotion-chasing Kent wrap up vital win

Promotion-chasing Kent wrapped up a seventh County Championship Division 2 victory of the summer in three days against Lancashire.

Ainsworth on ‘fierce competitor’ Evans as ex-Gills boss returns to Priestfield
Sep 17, 2026
Ainsworth on ‘fierce competitor’ Evans as ex-Gills boss returns to Priestfield

Steve Evans will bring his familiar touchline intensity back to Priestfield on Saturday – but Gills boss Gareth Ainsworth says he has his respect.

‘Horrible’ injury leaves Gillingham star sweating on Bristol Rovers clash
Sep 17, 2026
‘Horrible’ injury leaves Gillingham star sweating on Bristol Rovers clash

Gillingham are close to welcoming back several injured players for Saturday’s visit of Bristol Rovers – but striker Ronan Hale remains a doubt.

Gillingham defender rewarded with international call-up
Sep 17, 2026
Gillingham defender rewarded with international call-up

Gillingham defender Conor McManus has been called up for international duty.

Gillingham’s injury crisis has created a problem Ainsworth won’t mind
Sep 17, 2026
Gillingham’s injury crisis has created a problem Ainsworth won’t mind

Gillingham’s youngsters are making such an impression that some of the club’s senior players could find it difficult to win their shirts back.

Football fixtures and results
Sep 16, 2026
Football fixtures and results

Catch up with all the week’s football fixtures and results here.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily Sports Global

Daily Sports Global, your guide to the best sports news on the Internet. Access to the world’s biggest sports events right here even if you’re not physically there.

Newsletter